Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mammalian cell membranes and intracellular components encompass the complex network of lipid bilayers and organelles that define the structural and functional boundaries of a cell. The plasma membrane acts as a selective barrier, composed of a phospholipid bilayer with embedded proteins that facilitate communication and transport between the cell and its environment (Alberts et al., 2002, Molecular Biology of the Cell). Intracellular components, such as the mitochondria, endoplasmic reticulum, and nucleus, provide specialized environments for metabolism, protein synthesis, and genetic storage. While specific molecules within these structures are frequently targeted by drugs, the collective assembly is generally considered too broad to be a single therapeutic target. Drugs that interact non-specifically with these components, such as certain anesthetics or membrane-disrupting agents, often pose significant safety risks due to their potential to cause widespread cellular damage and systemic toxicity (Lodish et al., 2000, Molecular Cell Biology). These interactions can alter physical properties like membrane fluidity or lead to the direct lysis of the cell (StatPearls, 2023). Consequently, therapeutic development usually focuses on specific proteins or pathways within these structures rather than the structures themselves (Cooper, 2000, The Cell: A Molecular Approach).
Drugs interacting with these structures typically act through non-specific physical-chemical mechanisms, such as the alteration of membrane fluidity, disruption of the phospholipid bilayer integrity, or the formation of ion-conducting pores (StatPearls, 2023; PubMed, PMID: 24510513).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mammalian cell membranes and intracellular components.